Ibrance is indicated for the treatment of hormone receptor-positive locally advanced or metastatic breast cancer. To ensure the effectiveness of the treatment, the patient must strictly follow the instructions of the doctor.

Kryxana® is used to treat a type of advanced or metastatic breast cancer in premenopausal or postmenopausal women. During use, the drug can cause some unwanted side effects. Therefore, the patient should strictly follow the instructions when taking the drug.

Aromasin has the active ingredient Exemestane- which is a selective, irreversible steroid aromatase inhibitor. It is used as adjuvant treatment of estrogen-receptor positive postmenopausal women or unknown early breast cancer to reduce the risk of breast cancer recurrence. (spread and localized) and contralateral breast cancer.

Meirara là thuốc kê đơn bắt buộc được chỉ định trong điều trị ung thư vú tiến triển ở phụ nữ sau mãn kinh, đã thất bại khi điều trị nội khoa khác. Vậy thuốc Meirara có tác dụng gì? Những lưu ý khi sử dụng thuốc là gì?

Breast cancer is a common type of cancer in women, biological drugs are used to bring survival time but still have a high rate of recurrence and metastasis. Treatment with immunotherapy drugs has opened up new avenues for cancer patients.

On October 13, 2021, FDA (Food and Drug Administration) – US approved a new drug for the treatment of early breast cancer, believed to be the first real progress in 20 years. five. The drug is called abemaciclib - brand name Verzenio. So what is that drug? What effect? Learn about new drugs for early-stage breast cancer.